characteristics.text: SAMN35340804
characteristics.characteristic: External Id
characteristics.text: Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science
characteristics.characteristic: INSDC center name
characteristics.text: 2024-04-01T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-04-01T07:36:27.352Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS17955872
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS17955872
characteristics.characteristic: SRA accession
characteristics.text: pooled male and female
characteristics.characteristic: Sex
characteristics.text: Multiplexed sample: ages range 34-41
characteristics.characteristic: age
characteristics.text: CD14- CD19- CD3+ [CD45RA- or CD27-] CD4- T cells
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: multiplexed sample: 1 week after second or third shot
characteristics.characteristic: condition
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Peripheral blood T cells
characteristics.characteristic: source_name
characteristics.text: Batch2-2_Target
characteristics.characteristic: title
characteristics.text: Three shots of Pfizer-BNT162b2 vaccine
characteristics.characteristic: treatment